FDA Approved: DACTINOMYCIN — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved the original ANDA for dactinomycin (generic) to Eugia US LLC, enabling generic manufacturing and distribution of this anticancer agent.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Rhabdomyosarcoma
• Wilms Tumor

Drugs mentioned

• Dactinomycin (dactinomycin)

Snippet

ORIG AP for DACTINOMYCIN (DACTINOMYCIN)